Matteo Arata, MD

Department of Molecular Biotechnology and Health Sciences, University of Torino & University Division of Hematology, A.O.U. CIttà della Salute e della Scienza di Torino, Italy

Poster(s):

• 1403 - Factors Influencing the Regimen choice for firSt-line Therapy in Chronic Lymphocytic Leukemia: the FIRST-CLL study